|Articles|April 1, 2003

April 2003
Volume 9
Issue 4

Prescription Drugs: Elderly Enrollee Reports of Financial Access, Receipt of Free Samples, and Discussion of Generic Equivalents Related to Type of Coverage

Author(s)Deborah A. Taira, ScD, Kimberly A. Iwane, BS, Richard S. Chung, MD

Download PDF: Prescription Drugs: Elderly Enrollee Reports of Financial Access, Receipt of Free Samples, and Discussion of Generic Equivalents Related to Type of Coverage

Articles in this issue

almost 23 years ago

Article

Difference in the Use of Preventive Services Between Fee-for-Service Plans and HMOs: Is More Better?

almost 23 years ago

Article

Pediatric Combination Vaccines: Their Impact on Patients, Providers, Managed Care Organizations, and Manufacturers

almost 23 years ago

Article

Restoring Trust to Managed Care, Part 3: A Focus on Public Stakeholders

almost 23 years ago

Article

Pathophysiology and Management of Neurocardiogenic Syncope

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Prescription Drugs: Elderly Enrollee Reports of Financial Access, Receipt of Free Samples, and Discussion of Generic Equivalents Related to Type of Coverage

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

CMS Proposes Nearly Flat 2027 Medicare Advantage Payment Rates

Unexplained Pauses Hit Nearly Half of Monthly-Updated CDC Databases, Raising Transparency Concerns

ACE Inhibitors Linked to Reduced Mortality in Patients with Idiopathic Pulmonary Fibrosis

Clinical Trial Data Signal a New Era for Atopic Dermatitis, Melanoma, and Psoriasis

Catching Unethical Loopholes in ICD-10 Code Billing: Daniel Siegel, MD